Guo Yanhua, Ding Shouyang, Guo Hui, Li Shenqiu, Lu Xia, Chen Zhishui, Chen Zhonghua Klaus, Ming Changsheng, Gong Nianqiao
Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan Department of Transplantation, Central Hospital of Yiyang, Yiyang Department of Dermatology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Medicine (Baltimore). 2017 Jun;96(26):e7333. doi: 10.1097/MD.0000000000007333.
Acute graft-versus-host-disease (GVHD) in kidney recipients is extremely rare. Knowledge about its clinical manifestations, diagnosis, treatment, and prognosis is limited and needs to be increased.
One male kidney transplant recipient developed diarrhea and suffered kidney function damage. Primarily diagnosed with acute rejection, he was given methylprednisolone (MP) bolus treatment. Meanwhile, intravenous immunoglobulin (IVIG) and decreased immunosuppressive agents were applied for the corresponding infection. During the treatment, skin rashes occurred over his whole body. Biopsies were then taken. The pathology of the kidney graft showed no rejection, while the skin pathology revealed typical GVHD. Furthermore, fluorescence in situ hybridization proved the presence of donor-derived cells in the skin lesions, and infiltrating cytotoxic T cells and NK cells were identified in the rash.
Based on the clinical presentations, pathological findings, and chimerism detection, GVHD after kidney transplantation was confirmed as the final diagnosis. The recipient responded well to treatment. His kidney function recovered, and the skin lesions were completely resolved. He has been followed for 1 year without any further episodes.
GVHD after kidney transplantation has its own characteristics. In the presence of a highly immunocompromised state, diarrhea and rashes, a diagnosis of GVHD needs to be considered. Kidney function impairment may be involved. Pathological changes and detection of chimerism and immunocyte infiltration are required for diagnosis. MP bolus, IVIG, and decreased immunosuppression could be beneficial to the clinical outcome. Kidney recipients have a prognosis superior to recipients of organs bearing large numbers of lymphocytes.
肾移植受者发生急性移植物抗宿主病(GVHD)极为罕见。关于其临床表现、诊断、治疗及预后的知识有限,需要增加了解。
一名男性肾移植受者出现腹泻并伴有肾功能损害。最初诊断为急性排斥反应,给予甲泼尼龙(MP)冲击治疗。同时,针对相应感染应用静脉注射免疫球蛋白(IVIG)并减少免疫抑制剂用量。治疗期间,患者全身出现皮疹。随后进行活检。移植肾病理显示无排斥反应,而皮肤病理显示典型的GVHD。此外,荧光原位杂交证实皮肤病变中存在供体来源的细胞,且在皮疹中鉴定出浸润的细胞毒性T细胞和NK细胞。
根据临床表现、病理发现及嵌合体检测,最终确诊为肾移植后GVHD。患者对治疗反应良好。其肾功能恢复,皮肤病变完全消退。随访1年无复发。
肾移植后GVHD有其自身特点。在高度免疫抑制状态下,出现腹泻和皮疹时,需考虑GVHD诊断。可能累及肾功能损害。诊断需要病理改变、嵌合体检测及免疫细胞浸润检测。MP冲击、IVIG及减少免疫抑制可能有利于临床结局。肾移植受者的预后优于大量淋巴细胞器官的移植受者。